Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalized TNF-alpha inhibitor dosing guided by serum drug concentration in rheumatic disease
2015-004173-32Phase 4Completed
- Sponsor
- Aarhus University Hospital
- Start
- Oct 2015
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of etanercept, adalimumab and infliximab in rheumatism and rheumatoid arthritis (RA) (2 arms), sponsored by Aarhus University Hospital. Started Oct 2015; status: completed.
02
Drugs
03
Conditions
rheumatismrheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2015-004173-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004173-32.